These stocks are seeing heavy premarket action, put them on your watchlist for the day.
KULR Technology Group Inc (NYSEAMERICAN:KULR) More Than Doubled on Big News
KULR is one of the biggest percentage gainers as the stock is all set to gap up. The stock soared 102% to $4.58. The stock is seeing buying interest after it received a special permit from the U.S. Department of Transportation (DoT) authorizing the transport of prototype lithium cells and batteries aboard cargo aircrafts. Prototype lithium batteries are only authorized to be transported on cargo carrying aircrafts to, from or within the US when approved by DOT.
Midatech Pharma PLC-ADR (NASDAQ:MTP) Announces Key Data, Stock Jumps 50% in Pre-Market
MTP is the another big gainer with a jump of 50.50% to $3.07 in the pre-market session. Investors are cheering the MTP’s announcement about the breakthrough in vitro data which demonstrate Q-Sphera’s potential to formulate proteins into long-acting injectable products, as well as significant progress across multiple other programmes. In the 13 months since the announcement of a Strategic Review, the Company has shut down its Bilbao operations, thereby halving its monthly cash burn rate and pivoted from a largely singular focus on one Phase III ready asset (MTD201, Q-Sphera octreotide) to ‘multiple shots on goal’ with an expanded pipeline of nine earlier stage programmes.
Cellect Biotechnology Ltd – ADR (NASDAQ:APOP) Up 38% After Proposed Strategic Merger Agreement
Cellect Biotechnology Ltd – ADR (NASDAQ:APOP) is one of the biggest percentage gainers as the stock gained 38.500% to trade at $4.53. The stock is reacting to the news that Cellect Biotechnology has filed a registration statement, including a joint proxy statement/prospectus (“Proxy Statement”), with the Securities and Exchange Commission (SEC) in connection with its proposed strategic merger with privately-held Quoin Pharmaceuticals. The Company believes the progress of Quoin’s clinical programs, and the secured investments of $25.5 million, will benefit and maximize Cellect shareholders.
